Xiaobao Yang
8Patents
1h-index
25Co-inventors
43Inventor score
Filing activity: Dec 7, 2017 → Nov 1, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11771709B2 | ALK protein degradation agent and anti-tumor application thereof | Human Necessities | 1 | Active |
| US11541051B2 | Compositions and methods for treating CDK4/6-mediated cancer | Chemistry; Metallurgy | 1 | Active |
| US12226424B2 | Target protein degradation compounds, their anti-tumor use, their intermediates and use of intermediates | Chemistry; Metallurgy | 0 | Active |
| US12390532B2 | ALK protein regulator and anti-tumor application thereof | Chemistry; Metallurgy | 0 | Active |
| US11285150B2 | Compositions and methods for treating CDK4/6-mediated cancer | General | 0 | Revoked |
| US12274697B2 | Compositions and methods for treating EZH2-mediated cancer | Chemistry; Metallurgy | 0 | Active |
| US11510920B2 | Compositions and methods for treating EZH2-mediated cancer | Chemistry; Metallurgy | 0 | Active |
| US11639343B2 | Compounds targeting and degrading BCR-ABL protein and its antitumor application | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.